Inventaire - your friends and communities are your best library

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

Author

Corinna Burger

Published in: Molecular Therapy

Date of publication: August 1, 2004

Main subject: nervous system

Bibliographic databases:

Cites articles 76

Date

Title

Authors

September 1, 1987

The efficiency of systematic sampling in stereology and its prediction
December 1991

Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator,Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator
October 1, 1994

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
March 1, 1996

Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector
November 1, 1996

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
May 1, 1996

Gene transfer into the mouse retina mediated by an adeno-associated viral vector
July 1, 1996

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
November 1, 1996

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
November 1, 1997

Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice,Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent Mice
July 1, 1997

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
June 1, 1997

Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
March 1, 1997

Gene transfer by adeno-associated virus vectors into the central nervous system
January 1, 1997

Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters
December 1, 1997

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats,Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats
January 1, 1997

Developmental expression of platelet-derived growth factor alpha-receptor in neurons and glial cells of the mouse CNS
August 1, 1998

Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa

,
November 1, 1998

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
June 1, 1998

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease,Characterization of Intrastriatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer of Human Tyrosine Hydroxylase and Human GTP-Cyclohydrolase I in a Rat Model of Parkinson’s Disease
August 1, 1998

Regulation of gene expression in vivo following transduction by two separate rAAV vectors
April 1, 1998

Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors,Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors
May 1, 1998

Selective and rapid uptake of adeno-associated virus type 2 in brain,Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain
May 1, 1998

Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS
January 1, 1998

Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus
December 1, 1998

Novel tools for production and purification of recombinant adenoassociated virus vectors
February 1998

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions,Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions
January 1, 1999

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression
January 1, 1999

Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice
January 1, 1999

Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice
November 1, 1999

Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease
February 1, 1999

Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus
January 1, 1999

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection
June 1, 1999

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

Article -

Welcome to inventaire

The library of your friends and communities

Learn more